Off-label Use

Asrar Qureshi’s blog post discusses the unique ethical challenges of pharmaceutical marketing, emphasizing the distinction between customers (doctors) and consumers (patients). It highlights issues like misleading advertising, targeting vulnerable populations, off-label promotions, exaggerated disease prevalence, and undue influence on healthcare decision-making. Collaboration is essential to promote ethical practices in the industry.